Author: OurCrowd

[AEYE Health in PR Newswire] AEYE Health Welcomes Renowned Physician Guillermo Umpierrez, MD, CDCES as New Medical Board Advisor, and Prepares for Engaging Exhibitions at ENDO 2023 and ADA’s 83rd Scientific Sessions

NEW YORK, June 13, 2023 /PRNewswire/ — AEYE Health, a leading provider of AI-based diagnostic screening solutions, is thrilled to announce the appointment of Guillermo Umpierrez, MD, CDCES, as its newest Medical Board Advisor. Dr. Umpierrez, President, Medicine & Science of the American Diabetes Association (ADA), is renowned for his expertise in endocrinology and diabetes care and brings invaluable knowledge and experience to AEYE Health’s team. Read more...

Read More

[BlueGreen Water Technologies in Newswires] El Niño increases likelihood of toxic algal blooms in 2023

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, June 12, 2023/EINPresswire.com/ — NOAA confirms the beginning of El Niño, a climate phenomenon that produces above-average sea-surface temperatures in the Pacific Ocean, shifting global weather patterns. Forecasters expect El Niño to persist through summer and into fall, which coincides with peak toxic algae season in many parts of the U.S. Read more...

Read More

[Morphisec in Benzinga] Morphisec recognized as a Sample Vendor in Gartner® Emerging Tech: Security – Emergence Cycle for Automated Moving Target Defense Report

Securing operatBOSTON and BEER-SHEVA, Israel, June 12, 2023 /PRNewswire-PRWeb/ — Morphisec, the world’s leading provider of prevention-first endpoint security software, today announced its recognition as a sample vendor in Gartner Emerging Tech: Security — Emergence Cycle for Automated Moving Target Defense[1]. Automated Moving Target Defense (AMTD) technologies use polymorphism to move, change, obfuscate or morph attack surfaces to disrupt adversary cyber kill chains.ional technology (OT) creates unique challenges. Zero tolerance of downtime in factories, ports, banks, treatment plants, and other OT environments means that standard security practices like patch management or deploying protective solutions onto endpoints can be almost impossible to uphold. Read more...

Read More

[OncoHost in Onco’Zine] A multicomponent biomarker approach will shift cancer care

For many years we have been working towards creating a paradigm shift in cancer care, and precision oncology is rapidly evolving, with the potential to revolutionize our current standards and guidelines. But while we have made giant strides in our understanding of the disease, the current approach to biomarker development is still simplistic and fragmented, limiting our ability to understand the underlying biology of the patient’s cancer, tailor treatment to individual patients, monitor treatment response, detect early signs of relapse, and identify potential new targets for therapy. True precision oncology requires a comprehensive and integrated approach to biomarker development to really make a dent. Read...

Read More